April 29th 2024
The CDMO’s boost in production will be centered around pharmaceutical products.
April 25th 2024
The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.
The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.
April 9th 2024
The acquisition initiates a long-term agreement with Beacon Therapeutics, highlighted by clinical and commercial AAV production.
March 22nd 2024
The purpose for the deal, the CDMO says, is to meet the demand for commercial mammalian contract manufacturing.
A Dive into the World of ULT
Ultra low-temperature freezers continue to change the game in cold chain
WuXi STA Breaks Ground on New Pharma Manufacturing Site in Delaware
Site expected to boost the CDMO’s global drug production capabilities
Almac Group Reveals North American HQ Expansion Plan
Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity
Catalent Purchases Metrics Contract Services for $475 Million
Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity
SCHOTT Creates Stand-alone Company for Pharma Business
Division will operate under SCHOTT Pharma AG & Co. KGaA
PCI Pharma Services Expands UK Manufacturing Facility
CDMO’s new project focuses on addressing needs in oncology sector
Samsung Biologics Acquires Land for ‘Bio Campus II’
New property is valued at $323 million
WuXi Biologics to Grow Its DS/DP Capacity in Singapore
Center will feature a $1.4 billion investment plan
Wacker to Begin Building mRNA Actives Competence Center
Production capacity for the contract manufacturer is expected to more than triple
Fujifilm Invests $1.6 Billion toward Expansion of Cell Culture Manufacturing Services
Will benefit CDMO’s Denmark and Texas locations
Lonza to Construct Fill-finish Facility in Switzerland
With a cost of approximately $514 million, expected completion is 2026
Charles River Debuts UK Manufacturing Site
Cheshire facility will offer plasmid DNA production, CGT development
WuXi STA Opens HPAPI Facility in Changzhou, China
Marks the CDMO’s second plant in the country
BioNTech Breaks Ground on First mRNA Vaccine Manufacturing Facility in Africa
Containers to potentially be operational by next year, 2024 at the latest
MilliporeSigma Opens $65 Million HPAPI Facility
CDMO looks to combat cancer at lower doses
EMA Starts Rolling Review of Adapted COVID-19 Vaccines
Agency will be reviewing laboratory study and CMC data on the bivalent jab that targets two strains of the SARS-CoV-2 virus
Avid Bioservices Completes Phase One of Viral Vector Facility Construction
CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment
Exothera Forms AAV Manufacturing Collaboration
Partnership aims to compare reproducibility and comparability between different suspension bioreactors
BioCina Unveils pDNA Manufacturing Suite
New service offering is GMP compliant, with single-use fermentation capacity of up to 300 L
Piramal Pharma Boosts API Services
Focus on operational excellence is playing a major role in this effort, company says
SK Pharmteco to Invest $35 Million toward Site Expansion
CDMO’s Ireland campus will increase in capacity by 50% as a result
Yourway to Construct Depot in Ireland
Will serve as a hub, as company aims for growth in the European region
REGENXBIO Opens Gene Therapy Manufacturing Center
GMP facility allows for an increase in AAV vector production
The Impact of War on Drug Supply Chain
A conversation with EY life sciences leaders Jim Welch and Jay Welsh
Dealing with Dangerous Goods
The packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic
Navigating Uneven Terrain in Labeling
The crucial link of labeling and packaging in the pharma supply chain has its glory, but is not without its set of obstacles amid current market and global challenges
Coriolis Pharma to Expand German HQ
Project is expected to grow CRDO’s capacity by over 150,000 square feet
Via Partnership, Evonik and US Government Invest $220 Million toward Lipid Production Plant
Facility, with expected completion of 2025, will specialize in mRNA-based therapies
Piramal Pharma Advances Oral Solid Dose Capabilities
As a result of new production area, India site’s total production capacity rises from 3 to 4.5 billion doses
Catalent Commits $175 Million to Upgrading Kentucky Facility
Investment will grow manufacturing capabilities at Winchester site